Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TSMC | 4.90% | $877.10K | $1.58T | 100.12% | 81 Outperform | |
| Advantest | 4.79% | $856.96K | $109.24B | 201.39% | 59 Neutral | |
| Novartis | 4.23% | $757.86K | $295.46B | 43.41% | 80 Outperform | |
| ASML Holding | 3.99% | $715.22K | $529.02B | 97.15% | 81 Outperform | |
| Roche Holding | 3.70% | $661.80K | $337.96B | 22.68% | 74 Outperform | |
| Telefonaktiebolaget LM Ericsson | 3.11% | $555.94K | $38.16B | 42.89% | 74 Outperform | |
| Jazz Pharmaceuticals | 2.90% | $518.93K | $11.42B | 38.22% | 64 Neutral | |
| Rolls-Royce | 2.86% | $512.38K | $146.62B | 72.06% | 63 Neutral | |
| H World Group | 2.80% | $502.10K | $15.80B | 41.94% | 74 Outperform | |
| Siemens Energy | 2.78% | $497.40K | $152.16B | 183.06% | 76 Outperform |